Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis
Authors
Keywords
-
Journal
LEUKEMIA
Volume 31, Issue 12, Pages 2709-2716
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1038/leu.2017.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells
- (2016) Xiaoli Wang et al. BLOOD
- Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
- (2016) A. Jakubowiak et al. BLOOD
- Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
- (2016) A. A. Zahr et al. HAEMATOLOGICA
- Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
- (2016) Srdan Verstovsek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies
- (2016) A. A. Zahr et al. HAEMATOLOGICA
- Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1
- (2015) Michihiro Hashimoto et al. JOURNAL OF IMMUNOLOGY
- The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm
- (2014) V. Sangkhae et al. BLOOD
- Thrombopoietin from beginning to end
- (2014) Ian S. Hitchcock et al. BRITISH JOURNAL OF HAEMATOLOGY
- CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
- (2013) André Veillette et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model
- (2013) Barbara Reich et al. KIDNEY INTERNATIONAL
- U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype
- (2013) A Tefferi et al. LEUKEMIA
- Anti-transforming growth factor-β therapy in patients with myelofibrosis
- (2013) John Mascarenhas et al. LEUKEMIA & LYMPHOMA
- Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
- (2013) Pedro Ramos et al. NATURE MEDICINE
- FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation
- (2012) Jeffrey R. Crawford et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- PRM-151 (recombinant human serum amyloid P/pentraxin 2) for the treatment of fibrosis
- (2010) J.S. Duffield et al. DRUG NEWS & PERSPECTIVES
- Improved serum-free culture conditions for spleen-derived murine fibrocytes
- (2010) Jeffrey R. Crawford et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
- (2009) D. J. Kuter et al. BLOOD
- Improved serum-free culture conditions for the differentiation of human and murine fibrocytes
- (2009) Darrell Pilling et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts
- (2009) Darrell Pilling et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started